Correction: Circulating levels of soluble Dipeptidylpeptidase-4 are reduced in human subjects hospitalized for severe COVID-19 infections
Int J Obes (Lond)
.
2022 Jan;46(1):243.
doi: 10.1038/s41366-021-00988-y.
Authors
Kristina Schlicht
#
1
,
Nathalie Rohmann
#
1
,
Corinna Geisler
1
,
Tim Hollstein
1
,
Carina Knappe
1
,
Katharina Hartmann
1
,
Jeanette Schwarz
2
3
,
Florian Tran
3
4
,
Domagoj Schunk
5
,
Ralf Junker
2
,
Thomas Bahmer
4
,
Philip Rosenstiel
3
,
Dominik Schulte
1
,
Kathrin Türk
1
,
Andre Franke
3
,
Stefan Schreiber
1
3
,
Matthias Laudes
6
Affiliations
1
Division of Endocrinology, Diabetes and Clinical Nutrition, Department of Medicine 1, University of Kiel, Kiel, Germany.
2
Institute of Clinical Chemistry, University of Kiel, Kiel, Germany.
3
Institute of Clinical Molecular Biology, University of Kiel, Kiel, Germany.
4
Division of Pneumology, Department of Medicine 1, University of Kiel, Kiel, Germany.
5
Interdisciplinary Emergency Center, University of Kiel, Kiel, Germany.
6
Division of Endocrinology, Diabetes and Clinical Nutrition, Department of Medicine 1, University of Kiel, Kiel, Germany. matthias.laudes@uksh.de.
#
Contributed equally.
PMID:
34671109
PMCID:
PMC8526988
DOI:
10.1038/s41366-021-00988-y
No abstract available
Publication types
Published Erratum